Fengmin Zhao Selected Research

Fengmin Zhao Research Topics

Disease

29	Neoplasms (Cancer) 03/2024 - 03/2012
17	Breast Neoplasms (Breast Cancer) 01/2024 - 03/2012
8	Melanoma (Melanoma, Malignant) 09/2017 - 01/2013
7	Fatigue 01/2022 - 02/2014
3	Triple Negative Breast Neoplasms 01/2024 - 07/2015
2	Colonic Neoplasms (Colon Cancer) 02/2023 - 01/2020
2	Lymphoma (Lymphomas) 10/2022 - 01/2020
2	Disease Progression 01/2022 - 01/2018
2	Pain (Aches) 01/2022 - 02/2014
2	Diarrhea 01/2020 - 01/2018
2	Obesity 07/2015 - 12/2012
1	Multiple Myeloma 03/2024
1	Lymphedema (Milroy Disease) 12/2021
1	Residual Neoplasm 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2020
1	Adenocarcinoma 01/2020
1	Leukopenia 01/2020
1	Neutropenia 01/2020
1	Rectal Neoplasms (Rectal Cancer) 01/2020
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2019
1	Stomatitis 01/2018
1	Hypertriglyceridemia 01/2018
1	Exanthema (Rash) 01/2018
1	Hyperglycemia 01/2018
1	Anemia 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Squamous Cell Carcinoma of Head and Neck 03/2017
1	Carcinoma (Carcinomatosis) 03/2017

Drug/Important Bio-Agent (IBA)

11	Hormones (Hormone)IBA 01/2023 - 03/2012
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 09/2012
5	ErbB Receptors (EGF Receptor)IBA 10/2022 - 07/2015
5	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 01/2013
4	Aromatase InhibitorsIBA 10/2021 - 01/2018
4	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 01/2013
4	taxaneIBA 11/2015 - 09/2012
3	Fluorouracil (Carac)FDA LinkGeneric 02/2023 - 03/2017
3	exemestane (Aromasin)FDA Link 10/2021 - 01/2018
3	Peptides (Polypeptides)IBA 09/2017 - 08/2013
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2017 - 08/2013
2	PlatinumIBA 01/2024 - 10/2021
2	Capecitabine (Xeloda)FDA Link 01/2024 - 10/2021
2	Indicators and Reagents (Reagents)IBA 07/2023 - 12/2022
2	Bevacizumab (Avastin)FDA Link 12/2021 - 01/2020
2	Histone Deacetylase InhibitorsIBA 10/2021 - 01/2018
2	entinostat (MS 275)IBA 10/2021 - 01/2018
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 03/2017
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2013
2	CytokinesIBA 01/2017 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 09/2012
2	Docetaxel (Taxotere)FDA Link 07/2015 - 09/2012
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2015 - 09/2012
1	carfilzomibIBA 03/2024
1	Lenalidomide (CC 5013)FDA Link 03/2024
1	Bortezomib (Velcade)FDA Link 03/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024
1	copanlisibIBA 10/2022
1	human ERBB2 proteinIBA 10/2021
1	Aurora Kinase AIBA 01/2021
1	veliparibIBA 10/2020
1	Etoposide (VP 16)FDA LinkGeneric 10/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2020
1	trametinibIBA 01/2020
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020
1	Leucovorin (Folinic Acid)FDA Link 01/2020
1	Sunitinib (Sutent)FDA Link 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Everolimus FDA Link 01/2018
1	Fulvestrant (Faslodex)FDA Link 01/2018
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Vorinostat FDA Link 09/2017
1	Monatide (IMS 3015)IBA 09/2017
1	Protein Subunit VaccinesIBA 09/2017
1	AntigensIBA 09/2017
1	Trastuzumab (Herceptin)FDA Link 09/2017
1	Cetuximab (Erbitux)FDA Link 03/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	InterleukinsIBA 01/2017
1	Programmed Cell Death 1 ReceptorIBA 01/2017
1	LigandsIBA 01/2017
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2017
1	AutoantigensIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Immune Checkpoint ProteinsIBA 01/2017
1	InterferonsIBA 01/2017
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2017

Therapy/Procedure

27	Therapeutics 03/2024 - 03/2012
7	Drug Therapy (Chemotherapy) 02/2023 - 03/2012
3	Radiotherapy 01/2022 - 03/2017
2	Neoadjuvant Therapy 10/2021 - 01/2020
1	Colostomy 01/2020
1	Secondary Prevention 01/2020
1	Aftercare (After-Treatment) 09/2017
1	Chemoradiotherapy 03/2017